The judge ruled the "unjust enrichment" suit failed to even plausibly allege the "enrichment" of Abbott Labs — let alone the ...
Until the U.S. addresses the extreme concentration in the infant formula industry, the country is just one plant closure away ...
Robert Ford told investors the cases will start this summer, adding that "they're really seeking to advance a theory promoted ...
CHICAGO — A federal court in Illinois dismissed a nationwide class action brought by consumers against Abbott Labs, whose baby formula prices spiked during a 2022 recall of tainted formula. The court ...
When the FDA recently ... judgment of the Abbott product. The agency takes too narrow a view of what should be disqualifying, she said. One committee member was Craig Selzman, chief of the ...
Abbott has returned to the field of bio-absorbable, dissolving stents, and in somewhat uncharted territory. The company received a groundbreaking FDA approval for its latest drug-eluting scaffold ...
One member of the FDA ... Abbott in recent years to sit in judgment of the Abbott product. The agency takes too narrow a view of what should be disqualifying, she said. Dr. Craig Selzman, chief ...
Abbott earned a groundbreaking FDA approval on Monday for its dissolving stent designed to unclog arteries below the knee. The device, called the Esprit BTK System, is meant to treat patients who ...
One member of the FDA advisory ... of the Abbott product. The agency takes too narrow a view of what should be disqualifying, she said. One committee member was Dr. Craig Selzman, chief of the ...